tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMMP Stock Latest News

Immutep Reaches 50% Enrolment in Global Phase III Lung Cancer Trial
Company AnnouncementsImmutep Reaches 50% Enrolment in Global Phase III Lung Cancer Trial
4d ago
6K
IMMP
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
PremiumThe Fly
Immutep achieves 50% enrollment in global TACTI-004 Phase III trial
8d ago
IMMP
Immutep Secures Dr. Reddy’s Licensing Deal and Reports Strong Q2 FY26 Clinical and Cash Progress
PremiumCompany Announcements
Immutep Secures Dr. Reddy’s Licensing Deal and Reports Strong Q2 FY26 Clinical and Cash Progress
15d ago
6K
IMMP
Immutep reports Q2 cash receipts from customers A$4,000
PremiumThe Fly
Immutep reports Q2 cash receipts from customers A$4,000
16d ago
IMMP
Immutep Reports Positive Phase I Data for First-in-Class Autoimmune Antibody IMP761
PremiumCompany Announcements
Immutep Reports Positive Phase I Data for First-in-Class Autoimmune Antibody IMP761
2M ago
6K
IMMP
Immutep announces update on IMP761 from Phase I study
PremiumThe FlyImmutep announces update on IMP761 from Phase I study
2M ago
IMMP
Immutep Highlights Progress in TACTI-004 Phase III Cancer Trial
Premium
Company Announcements
Immutep Highlights Progress in TACTI-004 Phase III Cancer Trial
2M ago
6K
IMMP
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
Premium
The Fly
Immutep announces progress in global TACTI-004 Phase III, enrollment continues
2M ago
MRK
IMMP
Immutep’s Strategic Partnership with Dr. Reddy’s Fuels Growth Potential and Strengthens Financial Position
PremiumRatings
Immutep’s Strategic Partnership with Dr. Reddy’s Fuels Growth Potential and Strengthens Financial Position
2M ago
IMMP
Immutep and Dr. Reddy’s Forge Strategic Collaboration for Eftilagimod Alfa
PremiumCompany Announcements
Immutep and Dr. Reddy’s Forge Strategic Collaboration for Eftilagimod Alfa
2M ago
6K
IMMP
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
PremiumThe Fly
Midday Fly By: IBM to buy Confluent, Paramount goes hostile for Warner Bros.
2M ago
V
GM
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
PremiumThe Fly
Immutep, Dr Reddy’s enters strategic collaboration for Eftilagimod Alfa
2M ago
RDY
IMMP
Immutep to Present Promising AIPAC-003 Trial Data at SABCS 2025
PremiumCompany AnnouncementsImmutep to Present Promising AIPAC-003 Trial Data at SABCS 2025
2M ago
6K
IMMP
Immutep to present data from AIPAC-003 Phase II trial
Premium
The Fly
Immutep to present data from AIPAC-003 Phase II trial
2M ago
IMMP
Immutep’s EFTISARC-NEO Trial Shows Promising Results in Soft Tissue Sarcoma
Premium
Company Announcements
Immutep’s EFTISARC-NEO Trial Shows Promising Results in Soft Tissue Sarcoma
3M ago
6K
IMMP
Immutep announces data from EFTISARC-NEO trial
PremiumThe Fly
Immutep announces data from EFTISARC-NEO trial
3M ago
IMMP
Immutep Secures A$4.6 Million R&D Incentive from French Government
PremiumCompany Announcements
Immutep Secures A$4.6 Million R&D Incentive from French Government
3M ago
6K
IMMP
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
PremiumThe Fly
Immutep receives EUR 2,588,954 R&D tax incentive from French Government
3M ago
IMMP
Immutep Advances Key Clinical Trials and Strengthens Financial Position
PremiumCompany Announcements
Immutep Advances Key Clinical Trials and Strengthens Financial Position
4M ago
6K
IMMP
Immutep reports Q1 cash receipts from customers A$15,000
PremiumThe FlyImmutep reports Q1 cash receipts from customers A$15,000
4M ago
IMMP
Immutep Showcases Promising Lung Cancer Treatment Results at ESMO Congress 2025
Premium
Company Announcements
Immutep Showcases Promising Lung Cancer Treatment Results at ESMO Congress 2025
4M ago
6K
IMMP
Immutep Announces Breakthrough Results in Soft Tissue Sarcoma Trial
Premium
Company Announcements
Immutep Announces Breakthrough Results in Soft Tissue Sarcoma Trial
4M ago
6K
IMMP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >